Back
Vaccitech

Vaccitech

vaccitech.co.uk

Vaccitech is a clinical stage biotech company utilising T cell mediated immune responses to treat and prevent infectious diseases and cancer. The company was a co-inventor of the Oxford/AstraZeneca Covid-19 vaccine and went public in May 2021.

What
Life Sciences
When
Mar 2016
CEO
Bill Enright
Status
Public
Investment
Active
OSE Board Director
Alex Hammacher